La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Aspen Pharmacare Holdings Gestione
Gestione criteri di controllo 4/4
Aspen Pharmacare Holdings' Il CEO è Stephen Saad, nominato in Jan2000, e ha un mandato di 24.58 anni. la retribuzione annua totale è ZAR 24.15M, composta da 38% di stipendio e 62% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 12.84% delle azioni della società, per un valore di ZAR 13.36B. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 7.4 anni e 5.3 anni.
Informazioni chiave
Stephen Saad
Amministratore delegato
R24.1m
Compenso totale
| Percentuale dello stipendio del CEO | 38.0% |
| Mandato del CEO | 24.6yrs |
| Proprietà del CEO | 12.8% |
| Durata media del management | 7.4yrs |
| Durata media del Consiglio di amministrazione | 5.3yrs |
Aggiornamenti recenti sulla gestione
Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment
Dec 01
Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation
Dec 02Recent updates
We Think Aspen Pharmacare Holdings (JSE:APN) Can Stay On Top Of Its Debt
May 08Aspen Pharmacare Holdings Limited's (JSE:APN) P/E Still Appears To Be Reasonable
Mar 05Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet
Dec 22Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment
Dec 01Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet
Mar 31With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Makes An Interesting Case
Jan 11These 4 Measures Indicate That Aspen Pharmacare Holdings (JSE:APN) Is Using Debt Reasonably Well
Oct 22We Ran A Stock Scan For Earnings Growth And Aspen Pharmacare Holdings (JSE:APN) Passed With Ease
Oct 06Aspen Pharmacare Holdings' (JSE:APN) Upcoming Dividend Will Be Larger Than Last Year's
Sep 21Aspen Pharmacare Holdings Limited (JSE:APN) Analysts Just Cut Their EPS Forecasts Substantially
Sep 08Aspen Pharmacare Holdings (JSE:APN) Is Increasing Its Dividend To ZAR3.26
Sep 07Here's Why We Think Aspen Pharmacare Holdings (JSE:APN) Might Deserve Your Attention Today
Jun 15Aspen Pharmacare Holdings (JSE:APN) Seems To Use Debt Quite Sensibly
Apr 02With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Is Interesting
Mar 16An Intrinsic Calculation For Aspen Pharmacare Holdings Limited (JSE:APN) Suggests It's 33% Undervalued
Mar 02Is Aspen Pharmacare Holdings (JSE:APN) A Risky Investment?
Dec 23Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation
Dec 02We Think Aspen Pharmacare Holdings' (JSE:APN) Robust Earnings Are Conservative
Oct 11After Leaping 42% Aspen Pharmacare Holdings Limited (JSE:APN) Shares Are Not Flying Under The Radar
Sep 30Aspen Pharmacare Holdings Limited (JSE:APN) Looks Just Right With A 42% Price Jump
Sep 30Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | R5b |
| Sep 30 2023 | n/a | n/a | R5b |
| Jun 30 2023 | R24m | R9m | R5b |
| Mar 31 2023 | n/a | n/a | R6b |
| Dec 31 2022 | n/a | n/a | R6b |
| Sep 30 2022 | n/a | n/a | R6b |
| Jun 30 2022 | R23m | R9m | R6b |
| Mar 31 2022 | n/a | n/a | R6b |
| Dec 31 2021 | n/a | n/a | R6b |
| Sep 30 2021 | n/a | n/a | R5b |
| Jun 30 2021 | R24m | R8m | R5b |
| Mar 31 2021 | n/a | n/a | R4b |
| Dec 31 2020 | n/a | n/a | R4b |
| Sep 30 2020 | n/a | n/a | R4b |
| Jun 30 2020 | R23m | R8m | R3b |
| Mar 31 2020 | n/a | n/a | R3b |
| Dec 31 2019 | n/a | n/a | R870m |
| Sep 30 2019 | n/a | n/a | R1b |
| Jun 30 2019 | R14m | R8m | R2b |
| Mar 31 2019 | n/a | n/a | R3b |
| Dec 31 2018 | n/a | n/a | R5b |
| Sep 30 2018 | n/a | n/a | R5b |
| Jun 30 2018 | R17m | R7m | R6b |
Compensazione vs Mercato: La retribuzione totale di Stephen ($USD 1.35M ) è circa la media per le aziende di dimensioni simili nel mercato ZA ($USD 1.72M ).
Compensazione vs guadagni: La retribuzione di Stephen è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Stephen Saad (60 yo)
24.6yrs
Mandato
R24,149,000
Compensazione
Mr. Stephen Bradley Saad, BCom, CA(SA), serves as the Group Chief Executive Officer of Aspen Pharmacare Canada Inc. Mr. Stephen has been the Group Chief Executive Officer of Aspen Pharmacare Holdings Limit...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Group CEO & Executive Director | 24.6yrs | R24.15m | 12.84% ZAR 13.1b | |
| Group CFO & Executive Director | 25.6yrs | R15.55m | Nessun dato | |
| Group Chief Operations Officer & Responsible Pharmacist | 10.8yrs | R16.59m | Nessun dato | |
| Group Chief Advisor | 2.6yrs | R12.62m | 4.31% ZAR 4.4b | |
| Group Chief Corporate Services Officer & Executive Director | less than a year | R14.21m | Nessun dato | |
| Group Chief Strategic Development Officer | 4.3yrs | R13.87m | Nessun dato | |
| Investor Relations Manager | no data | Nessun dato | Nessun dato | |
| Regional Chief Executive Officer of Asia Pacific | 10.6yrs | Nessun dato | Nessun dato | |
| Chief Executive Officer of Aspen Global Incorporated | 7.4yrs | Nessun dato | Nessun dato | |
| Group Company Secretary | less than a year | Nessun dato | Nessun dato | |
| Corporate Affairs & Investor Relations Executive | no data | Nessun dato | Nessun dato |
7.4yrs
Durata media
54.5yo
Età media
Gestione esperta: Il team dirigenziale di APN è esperto e expertise (durata media dell'incarico 7.4 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Group CEO & Executive Director | 25.6yrs | R24.15m | 12.84% ZAR 13.1b | |
| Group CFO & Executive Director | 2.6yrs | R15.55m | Nessun dato | |
| Group Chief Corporate Services Officer & Executive Director | less than a year | R14.21m | Nessun dato | |
| Lead Independent Non-Executive Director | 5.3yrs | R932.00k | Nessun dato | |
| Non-Executive Director | 25.6yrs | R465.00k | Nessun dato | |
| Independent Non-Executive Chairman | 12.3yrs | R1.41m | Nessun dato | |
| Independent Non-Executive Director | 2.7yrs | R548.00k | Nessun dato | |
| Non-Executive Director | 9.5yrs | R364.00k | Nessun dato | |
| Independent Non-Executive Director | 6.1yrs | R958.00k | Nessun dato | |
| Independent Non-Executive Director | less than a year | Nessun dato | Nessun dato | |
| Independent Non-Executive Director | 5.3yrs | R448.00k | Nessun dato |
5.3yrs
Durata media
57yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di APN sono considerati esperti (durata media dell'incarico 5.3 anni).